Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy

Inflammatory Bowel Diseases

Volumn 15, Issue 7, 2009, Pages 1044-1048

  Branche, Julien ^a   Cortot, Antoine ^a   Bourreille, Arnaud ^b   Coffin, Benoit ^c,i   de Vos, Martine ^d   de Saussure, Philippe ^e   Seksik, Philippe ^f   Marteau, Philippe ^g   Lemann, Marc ^h   Colombel, Jean Frédéric ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL LOUIS MOURIER   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f HÔPITAL SAINT ANTOINE   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cyclosporine; Steroid refractory; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; INSULIN; STEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GESTATIONAL AGE; HUMAN; INFECTION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RECURRENT INFECTION; STOMATITIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; ULCERATIVE COLITIS; DRUG RESISTANCE; FOLLOW UP; HOSPITALIZATION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY;

ADULT; COLITIS, ULCERATIVE; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEROIDS;

EID: 69449093365     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20858     Document Type: Article

References (34)

1. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974;1:1067.
2. Truelove SC, Willoughby CP, Lee EG, et al. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet. 1978;2:1086.
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041.
4. Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med. 1987;80:492.
5. Dozois EJ, Wolff BG, Tremaine WJ, et al. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy: case series and literature review. Dis Colon Rectum. 2006;49:64.
6. Babaknia A, Parsa H, Woodruff JD. Appendicitis during pregnancy. Obstet Gynecol. 1977;50:40.
7. Hoffman ES, Suzuki M. Acute appendicitis in pregnancy; a ten-year survey. Am J Obstet Gynecol. 1954;67:1338.
8. Norgard B, Fonager K, Pedersen L, et al. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut. 2003;52:243.
9. Jayaprakash A, Gould S, Lim AG, et al. Use of cyclosporin in pregnancy. Gut. 2004;53:1386.
10. Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut. 2006;55:1364.
11. Reindl W, Schmid RM, Huber W. Cyclosporin A treatment of steroid-refractory ulcerative colitis during pregnancy: report of two cases. Gut. 2007;56:1019.
12. Bertschinger P, Himmelmann A, Risti B, et al. Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol. 1995; 90:330.
13. Reddy D, Murphy SJ, Kane SV, et al. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol. 2008;103:1203-1209.
14. Carbonnel F, Lavergne A, Lemann M, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci. 1994;39:1550.
15. Sternthal MB, Murphy SJ, George J, et al. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:937-943.
16. Van Assche G, D'Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology. 2003;125:1025.
17. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131:283.
18. Tendron-Franzin A, Gouyon JB, Guignard JP, et al. Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit. J Am Soc Nephrol. 2004;15:2687.
19. Brown PA, Gray ES, Whiting PH, et al. Effects of cyclosporin A on fetal development in the rat. Biol Neonate. 1985;48:172.
20. Mason RJ, Thomson AW, Whiting PH, et al. Cyclosporine-induced fetotoxicity in the rat. Transplantation. 1985;39:9.
21. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am. 1997;23:149.
22. Bar Oz B, Hackman R, Einarson T, et al. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71:1051.
23. Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity. 2003;36:51.
24. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830.
25. D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001;120:1323.
26. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330: 1841.
27. Shibolet O, Regushevskaya E, Brezis M, et al. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev. 2005:CD004277.
28. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353: 2462-2476.
29. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128:1805.
30. Katz JA, Antoni C, Keenan GF, et al. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99:2385.
31. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4:621.
32. Mahadevan U, Terdiman J, Church JA, et al. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology. 2007;132:960.
33. Vasiliauskas EA, Church JA, Silverman N, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255.
34. Travis SPL, Stange EF, Lemann M, et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohn's Colitis. 2008;2:24